Biotech Stock News (OREX) (ABBV) (PCYC) (GILD) (OHRP)

Orexigen Therapeutics (OREX) Shares of Orexigen Therapeutics were up 40% on 3/3/15 when the company announced that early safety data showed that Contrave was not only safe to take but in addition it was able to reduce a patient’s risk of generating cardiovascular health issues such as a heart-attack. Contrave was approved by the FDA … Read more